Image

Feasibility Study on Implementing Consultation-based High-quality Palliative Care Services in Intensive Care Units

Feasibility Study on Implementing Consultation-based High-quality Palliative Care Services in Intensive Care Units

Recruiting
19 years and older
All
Phase N/A

Powered by AI

Overview

Critically ill patients in intensive care units (ICUs) receive life-sustaining treatments aimed at restoring or maintaining organ function. ICU admission often involves substantial physical and existential pressures that can burden patients, their families, and surrogates. Multidisciplinary palliative care support can help alleviate potential causes of suffering. Twenty patients admitted to the ICUs at Seoul National University Hospital, diagnosed with sudden and severe acute brain injury or progressive organ failure, along with their surrogates, will be enrolled in the study. This study aims to assess the feasibility of applying consultation-based palliative care services to provide higher quality palliative care for critically ill patients with acute illnesses and their families facing poor prognoses upon ICU admission. Additionally, the study seeks to determine whether providing such palliative care services can help better respect the patient's values and goals, reduce communication conflicts, alleviate family caregivers' anxiety and depression, and enhance satisfaction with critical care.

Eligibility

Both patients and surrogates must meet the inclusion criteria and not fall under any exclusion criteria

[Inclusion Criteria]

Patients
  1. Diagnosis of sudden and severe acute brain injury due to at least one of the following etiologies: vascular, traumatic, metabolic, toxic, infectious, or anoxic AND
  2. Glasgow Coma Scale score of 3-8 for at least 24 hours after the patient's admission AND
  3. Unable to express themselves verbally or otherwise

OR

  1. Diagnosis of advanced stage organ failure (any of the following)
    • Chronic lung disease requiring long-term oxygen therapy or mechanical ventilation
    • Decompensated liver cirrhosis
    • Chronic heart failure with NYHA class III or IV
    • Progressive neurological disease with a modified Rankin score of 3-5 (e.g., dementia, Parkinson's disease, and amyotrophic lateral sclerosis)
    • Three or more chronic comorbidities causing limitations in activities of daily living (ADL) AND
  2. APACHE II score ≥ 14 at the time of screening AND
  3. ICU stay of 7 days or more
    Surrogates
  4. Family caregiver of a patient who meets the inclusion criteria (Family: defined as

    the patient's spouse, lineal ascendants and descendants within two degrees of kinship and their spouses, siblings and their spouses, and relatives within eight degrees of kinship and their spouses)

  5. Aged 19 or older
  6. Willing and able to provide consent for participation in the study

[Exclusion Criteria]

Patients
  1. Under 19 years of age
  2. Unable to speak, understand, or read Korean
  3. Refusal of palliative care consultation
  4. Referred to palliative care prior to study enrollment
  5. Within 48 hours of ICU admission
  6. Presence of active cancer under treatment within 6 months prior to ICU admission
  7. Care goals set to "comfort care" at the time of study enrollment
  8. Death expected within 48 hours at the time of study enrollment
  9. Lack of capacity to participate in the study without an appropriate surrogate
Surrogates
  1. Under 19 years of age
  2. Unable to speak, understand, or read Korean
  3. Determined by a physician to be in extremely poor health, making participation in the study infeasible
  4. Refusal of palliative care consultation

Study details
    Critical Illness

NCT06490835

Seoul National University Hospital

13 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.